360 High-Risk Vulnerability Immunization Tool V2.0 vs Malwarebytes: Side-by-Side Comparison (2026)

Short answer

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Small business security teams dealing with consumer device sprawl and identity theft risk should pick Malwarebytes for its AI-powered scam detection and bundled identity monitoring, which address threats that traditional EDR misses. The platform covers both NIST Detect and Protect functions through real-time malware prevention and personal data removal from public websites, hitting the compliance boxes that matter for startups. Skip this if you need endpoint detection and response for Windows servers or threat hunting capabilities; Malwarebytes is designed around individual device protection, not enterprise incident investigation.